Fibrosing cholestatic hepatitis developing within one month after living donor liver transplantation for chronic hepatitis c-related cirrhosis: A case report

Transplantation Proceedings

Volumn 46, Issue 3, 2014, Pages 995-998

  Murakami, K ^a   Kawagishi, N ^a   Ishida, K ^b   Sekiguchi, S ^a   Fujishima, F ^a   Sasano, H ^a   Ohuchi, N ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; BILIRUBIN; CYCLOSPORIN; METHYLPREDNISOLONE; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA; IMMUNOSUPPRESSIVE AGENT;

ADULT; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTATIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DOPPLER FLOWMETRY; FEMALE; FIBROSING CHOLESTATIC HEPATITIS; GENE; GENOTYPE; HEPATIC ARTERY THROMBOSIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERLEUKIN 28B GENE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; LIVING DONOR; MIDDLE AGED; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPLENORENAL SHUNT; COMPLICATION;

FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED;

EID: 84899513173     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.09.047     Document Type: Conference Paper

References (18)

1. T. Fukuhara, K. Morita, and K. Takeishi et al. Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case Surg Today 40 2010 982
2. S.E. Davies, B.C. Portmann, and J.G. O'Grady et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis Hepatology 13 1991 150
3. E.J. Gane, B.C. Portmann, and N.V. Naoumov et al. Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815
4. U.P. Neumann, T. Berg, and M. Bahra et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C J Hepatol 41 2004 830
5. J. Peveling-Oberhag, S. Zeuzem, and W.P. Hofmann Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation Med Microbiol Immunol 199 2010 1
6. S.K. Satapathy, S. Sclair, and M.I. Fiel et al. Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation Hepatol Res 41 2011 328
7. M. Berenguer, M. Prieto, and F. San Juan et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202
8. A.L. Doughty, J.D. Spencer, and Y.E. Cossart et al. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels Liver Transplant Surg 4 1998 15
9. L.K. Schluger, P.A. Sheiner, and S.N. Thung et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation Hepatology 23 1996 971
10. M. Taniguchi, H. Furukawa, and T. Shimamura et al. Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C Transplantation 81 2006 1747
11. Y. Takada, T. Ito, and Y. Ueda et al. Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation Liver Transpl 14 2008 1044
12. K. Watashi, and K. Shimotohno Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy Rev Med Virol 17 2007 245
13. W.D. Irish, S. Arcona, and D. Bowers et al. Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database Am J Transplant 11 2011 1676
14. Y. Tanaka, N. Nishida, and M. Sugiyama et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105
15. T. Fukuhara, A. Taketomi, and T. Motomura et al. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C Gastroenterology 139 2010 1577
16. M. Sugiyama, Y. Tanaka, and T. Wakita et al. Genetic variation of the IL-28B promoter affecting gene expression PLoS One 6 2011 e26620
17. S. Maekawa, and N. Enomoto Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C J Gastroenterol 44 2009 1009
18. S.Y. Xiao, L. Lu, and H.L. Wang Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis Int J Clinl Exp Pathol 1 2008 396